Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient
- 10 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 16 (5), 1066-1073
- https://doi.org/10.1007/s00330-005-0042-z
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Comparison of FDG PET and SPECT for Detection of Bone Metastases in Breast CancerAmerican Journal of Roentgenology, 2005
- Whole-Body MR Imaging: Evaluation of Patients for MetastasesRadiology, 2004
- 16-detector multislice CT: dosimetry estimation by TLD measurement compared with Monte Carlo simulationThe British Journal of Radiology, 2004
- Whole body magnetic resonance imagingBMJ, 2004
- Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.2004
- F-18 NaF PET for Detection of Bone Metastases in Lung Cancer: Accuracy, Cost-Effectiveness, and Impact on Patient ManagementJournal of Bone and Mineral Research, 2003
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeAnnals of Internal Medicine, 2003
- Three-Dimensional Volumetric Interpolated Breath-Hold MR Imaging for Whole-Body Tumor Staging in Less Than 15 Minutes: A Feasibility StudyAmerican Journal of Roentgenology, 2002
- Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.2001
- Improved confidence intervals for the difference between binomial proportions based on paired dataStatistics in Medicine, 1998